Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lotte Pyfferoen

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical Kidney Journal|March 18, 2016
The effects of vitamin K supplementation and vitamin K antagonists on progression of vascular calcification: ongoing randomized controlled trialsRogier Caluwé, Lotte Pyfferoen, Koen De Boeck, et al.
Neuroradiology|May 17, 2026
Advances in cranial nerve imaging: emerging MRI techniquesChristoph Kenis, Alexandra Libeert, Lotte Pyfferoen, et al.
European Radiology|June 5, 2016
Benchmarking pediatric cranial CT protocols using a dose tracking software system: a multicenter studyTimo De Bondt, Tom Mulkens, Federica Zanca, et al.
Insights Into Imaging|September 9, 2017
Benchmarking adult CT-dose levels to regional and national references using a dose-tracking software: a multicentre experienceLotte Pyfferoen, Tom H Mulkens, Federica Zanca, et al.
International Journal of Cancer|May 3, 2014
Lung tumours reprogram pulmonary dendritic cell immunogenicity at the microRNA levelLotte Pyfferoen, Pieter Mestdagh, Karl Vergote, et al.
Thyroid : Official Journal of the American Thyroid Association|April 11, 2018
"White Thyroid" on Unenhanced Computed Tomography in Amiodarone-Induced Thyrotoxicosis Type 2Annick Van den Bruel, Joost Delanote, Arnaud Braeckman, et al.
Journal of the American Society of Nephrology : JASN|November 10, 2019
Multicenter Randomized Controlled Trial of Vitamin K Antagonist Replacement by Rivaroxaban with or without Vitamin K2 in Hemodialysis Patients with Atrial Fibrillation: the Valkyrie StudyAn S De Vriese, Rogier Caluwé, Lotte Pyfferoen, et al.
Oncoimmunology|February 16, 2017
The transcriptome of lung tumor-infiltrating dendritic cells reveals a tumor-supporting phenotype and a microRNA signature with negative impact on clinical outcomeLotte Pyfferoen, Elisabeth Brabants, Celine Everaert, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical Kidney Journal|March 18, 2016
The effects of vitamin K supplementation and vitamin K antagonists on progression of vascular calcification: ongoing randomized controlled trialsRogier Caluwé, Lotte Pyfferoen, Koen De Boeck, et al.
Neuroradiology|May 17, 2026
Advances in cranial nerve imaging: emerging MRI techniquesChristoph Kenis, Alexandra Libeert, Lotte Pyfferoen, et al.
European Radiology|June 5, 2016
Benchmarking pediatric cranial CT protocols using a dose tracking software system: a multicenter studyTimo De Bondt, Tom Mulkens, Federica Zanca, et al.
Insights Into Imaging|September 9, 2017
Benchmarking adult CT-dose levels to regional and national references using a dose-tracking software: a multicentre experienceLotte Pyfferoen, Tom H Mulkens, Federica Zanca, et al.
International Journal of Cancer|May 3, 2014
Lung tumours reprogram pulmonary dendritic cell immunogenicity at the microRNA levelLotte Pyfferoen, Pieter Mestdagh, Karl Vergote, et al.
Thyroid : Official Journal of the American Thyroid Association|April 11, 2018
"White Thyroid" on Unenhanced Computed Tomography in Amiodarone-Induced Thyrotoxicosis Type 2Annick Van den Bruel, Joost Delanote, Arnaud Braeckman, et al.
Journal of the American Society of Nephrology : JASN|November 10, 2019
Multicenter Randomized Controlled Trial of Vitamin K Antagonist Replacement by Rivaroxaban with or without Vitamin K2 in Hemodialysis Patients with Atrial Fibrillation: the Valkyrie StudyAn S De Vriese, Rogier Caluwé, Lotte Pyfferoen, et al.
Oncoimmunology|February 16, 2017
The transcriptome of lung tumor-infiltrating dendritic cells reveals a tumor-supporting phenotype and a microRNA signature with negative impact on clinical outcomeLotte Pyfferoen, Elisabeth Brabants, Celine Everaert, et al.
Pageof 1